AHCLAnlon Healthcare Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
Why buy
- • ROE: 17.4%
- • ROCE: 16.8%
- • Debt/Equity: 0.17
- • MACD: bullish
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Breakout with Volume signal (setup quality 88%)
Bull case
- • ROE: 17.4%
- • ROCE: 16.8%
- • Debt/Equity: 0.17
- • MACD: bullish
Bear case
- • Revenue growth: 4.0% YoY
- • Profit growth: -54.8% YoY
- • Volatility: 50% annualized
- • Max drawdown (1y): 36%
Key risks
- • Revenue growth: 4.0% YoY
- • Profit growth: -54.8% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹0.82). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.